SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Emmaus Life Sciences, Inc. – ‘10-K’ for 9/30/16 – ‘EX-4.4’

On:  Thursday, 12/22/16, at 5:04pm ET   ·   For:  9/30/16   ·   Accession #:  1615774-16-9049   ·   File #:  1-35527

Previous ‘10-K’:  ‘10-K’ on 1/5/16 for 9/30/15   ·   Next:  ‘10-K’ on 12/29/17 for 9/30/17   ·   Latest:  ‘10-K’ on 3/31/23 for 12/31/22   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/22/16  Emmaus Life Sciences, Inc.        10-K        9/30/16   71:6.7M                                   S2 Filings LLC/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    882K 
 2: EX-3.1      Articles of Incorporation/Organization or Bylaws    HTML    105K 
 3: EX-4.4      Instrument Defining the Rights of Security Holders  HTML     35K 
 4: EX-4.5      Instrument Defining the Rights of Security Holders  HTML     51K 
 5: EX-4.6      Instrument Defining the Rights of Security Holders  HTML     50K 
 6: EX-10.23    Material Contract                                   HTML     35K 
 7: EX-10.24    Material Contract                                   HTML     59K 
 8: EX-21.1     Subsidiaries List                                   HTML     17K 
 9: EX-23.1     Consent of Experts or Counsel                       HTML     19K 
10: EX-31.1     Certification -- §302 - SOA'02                      HTML     25K 
11: EX-31.2     Certification -- §302 - SOA'02                      HTML     25K 
12: EX-32.1     Certification -- §906 - SOA'02                      HTML     21K 
13: EX-32.2     Certification -- §906 - SOA'02                      HTML     21K 
20: R1          Document and Entity Information                     HTML     49K 
21: R2          Consolidated Balance Sheets                         HTML    110K 
22: R3          Consolidated Balance Sheets (Parenthetical)         HTML     40K 
23: R4          Consolidated Statements of Operations               HTML     70K 
24: R5          Consolidated Statements of Changes in               HTML     63K 
                Stockholders' Deficit                                            
25: R6          Consolidated Statements of Cash Flows               HTML    100K 
26: R7          Nature of Operations                                HTML     41K 
27: R8          Summary of Significant Accounting Policies          HTML     66K 
28: R9          Convertible Debt and Equity Financings              HTML    136K 
29: R10         Derivative Liabilities                              HTML     59K 
30: R11         Stockholders' Deficit                               HTML    127K 
31: R12         Income Taxes                                        HTML     45K 
32: R13         Related Party Transactions                          HTML     40K 
33: R14         Loss Per Share                                      HTML     36K 
34: R15         Commitments and Contingent Liabilities              HTML     55K 
35: R16         Significant Customers                               HTML     25K 
36: R17         Subsequent Events                                   HTML     41K 
37: R18         Summary of Significant Accounting Policies          HTML    125K 
                (Policies)                                                       
38: R19         Summary of Significant Accounting Policies          HTML     28K 
                (Tables)                                                         
39: R20         Convertible Debt and Equity Financings (Tables)     HTML    114K 
40: R21         Derivative Liabilities (Tables)                     HTML     50K 
41: R22         Stockholders' Deficit (Tables)                      HTML    103K 
42: R23         Income Taxes (Tables)                               HTML     43K 
43: R24         Loss Per Share (Tables)                             HTML     33K 
44: R25         Commitments and Contingent Liabilities (Tables)     HTML     34K 
45: R26         Nature of Operations (Details Narrative)            HTML     62K 
46: R27         Summary of Significant Accounting Policies          HTML     30K 
                (Details)                                                        
47: R28         Summary of Significant Accounting Policies          HTML     75K 
                (Details Narrative)                                              
48: R29         Convertible Debt and Equity Financings (Details)    HTML    110K 
49: R30         Convertible Debt and Equity Financings (Details     HTML    105K 
                Narrative)                                                       
50: R31         Derivative Liabilities (Details)                    HTML     30K 
51: R32         Derivative Liabilities (Details 1)                  HTML     57K 
52: R33         Derivative Liabilities (Details Narrative)          HTML     86K 
53: R34         Stockholders' Deficit (Details)                     HTML     28K 
54: R35         Stockholders' Deficit (Details 1)                   HTML     42K 
55: R36         Stockholders' Deficit (Details 2)                   HTML    100K 
56: R37         Stockholders' Deficit (Details 3)                   HTML     45K 
57: R38         Stockholders' Deficit (Details 4)                   HTML     50K 
58: R39         Stockholders' Deficit (Details Narrative)           HTML    203K 
59: R40         Stockholders' Deficit (Details Narrative 1)         HTML     55K 
60: R41         Income Taxes (Details)                              HTML     37K 
61: R42         Income Taxes (Details 1)                            HTML     42K 
62: R43         Income Taxes (Details Narrative)                    HTML     25K 
63: R44         Related Party Transactions (Details Narrative)      HTML     88K 
64: R45         Loss Per Share (Details)                            HTML     39K 
65: R46         Commitments and Contingent Liabilities (Details)    HTML     56K 
66: R47         Commitments and Contingent Liabilities (Details     HTML    107K 
                Narrative)                                                       
67: R48         Significant Customers (Details Narrative)           HTML     30K 
68: R49         Subsequent Events (Details Narrative)               HTML    109K 
70: XML         IDEA XML File -- Filing Summary                      XML    111K 
69: EXCEL       IDEA Workbook of Financial Reports                  XLSX     89K 
14: EX-101.INS  XBRL Instance -- myan-20160930                       XML   2.01M 
16: EX-101.CAL  XBRL Calculations -- myan-20160930_cal               XML    143K 
17: EX-101.DEF  XBRL Definitions -- myan-20160930_def                XML    731K 
18: EX-101.LAB  XBRL Labels -- myan-20160930_lab                     XML   1.10M 
19: EX-101.PRE  XBRL Presentations -- myan-20160930_pre              XML    922K 
15: EX-101.SCH  XBRL Schema -- myan-20160930                         XSD    169K 
71: ZIP         XBRL Zipped Folder -- 0001615774-16-009049-xbrl      Zip    163K 


‘EX-4.4’   —   Instrument Defining the Rights of Security Holders


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 

Exhibit 4.4

 

Restricted SHARES Agreement

under the MYND ANALYTICS, INC.

Amended and Restated 2012 oMNIBUS INCENTIVE COMPENSATION Plan

 

Name of Grantee: [                  ] (the “Grantee”)
   
No. of Restricted Shares: [                      ] shares of the common stock (the “Restricted Shares”)
   
Grant Date: [                  ] (the “Grant Date”)

 

Pursuant to the terms of the MYnd Analytics, Inc. Amended and Restated 2012 Omnibus Incentive Compensation Plan (the “Plan”) and the resolutions of the board of directors of MYnd Analytics, Inc. (the “Company”) dated [              ], the Company hereby issues to the Grantee, as of the Grant Date set forth above, the number of shares of its common stock (“Common Stock”) set forth above (the “Restricted Shares”), in accordance with and subject to the terms and conditions set forth herein.

 

Notwithstanding anything in this Restricted Shares Agreement (the “Agreement”) to the contrary, the Restricted Shares granted herein shall be subject to, and governed by, all the terms and conditions of the Plan. To the extent there is any inconsistency between the terms of the Plan and of this Agreement, the terms of the Plan shall control.

 

All capitalized terms used in this Agreement and not otherwise defined shall have the respective meanings given such terms in the Plan.

 

Transfer Restrictions. The Restricted Shares may not be sold, assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by the Grantee, and any purported assignment, alienation, pledge, attachment, sale, transfer or encumbrance shall be void and unenforceable against the Company. The Restricted Shares shall be subject to a risk of forfeiture upon the Grantee’s Termination of Affiliation until the end of the applicable Vesting Date (as defined in Section 3 below) with respect to such shares.

 

Stock Power and Delivery of Restricted Shares. The Restricted Shares will be held by the Company for the Grantee until the applicable Vesting Date. Upon issuance of the Restricted Shares in the Grantee’s name, the Grantee will be the holder of record of the Restricted Shares and will have all rights of a shareholder with respect to such shares (including the right to vote such shares at any meeting of shareholders of the Company and the right to receive all dividends paid with respect to such shares), subject only to the terms and conditions imposed by this Agreement. The Grantee agrees to sign and deliver to the Company a stock power relating to the Restricted Shares.

 

 C: 
  C: 1 

 

 

If any of the Restricted Shares are forfeited hereunder at any time prior to the applicable Vesting Date of such Restricted Shares, the appropriate officers of the Company shall direct the transfer agent and registrar of the Company’s Common Stock to cause the book entry with respect to such Restricted Shares to be adjusted to reflect the number of Restricted Shares so forfeited..

 

Upon vesting of any of the Restricted Shares hereunder in accordance with Section 3 below, and the Grantee’s delivery to the Company of the amount necessary to satisfy the Company’s federal, state and local employment and income tax withholding obligation as provided in Section 5 below, the Company shall cancel the stock power with respect to such vested shares of Restricted Shares and the Company shall deliver such shares to the Grantee. Thereafter, such shares shall cease to be Restricted Shares and shall be nonforfeitable and freely transferable.

 

Vesting. The number of Restricted Shares set forth below shall vest as of the applicable “Vesting Dates” specified in the table below, provided that the Grantee has not had a Termination of Affiliation prior to such Vesting Date.

 

Restricted Shares Vesting Date

Shares vest on the [     ] of every month evenly over [     ] months, beginning on

[     ].

 

If the Grantee’s has a Termination of Affiliation for any reason prior to the Vesting Date, the Grantee will immediately forfeit all remaining Restricted Shares, and all of the Grantee’s rights to and interest in such remaining Restricted Shares shall terminate upon forfeiture without payment of any consideration.

 

Transfer Restrictions: Restrictive Legend. The Grantee understands that the Grantee has no right to transfer Restricted Shares prior to the Vesting Date applicable to such Restricted Shares and the Company may, without liability for its good faith actions, place legend restrictions upon the Restricted Shares and issue “stop transfer” instructions requiring compliance with the terms of the Plan and this Agreement.

 

Tax Withholding. The Grantee hereby acknowledges that the Grantee has been advised by the Company to seek independent tax advice regarding the availability and advisability of making an election under Section 83(b) of the Internal Revenue Code of 1986, as amended, and that any such election, if made, must be made within 30 days of the Grant Date. The Grantee is not relying on the Company or any of its officers, directors or employees for tax advice regarding the Restricted Shares granted in this Agreement. The Grantee bears sole responsibility for the filing any such Section 83(b) election with the appropriate governmental authorities, irrespective of the fact that a copy of such election will also be delivered to the Company. The Grantee agrees to promptly notify the Company in the event the Grantee makes a Section 83(b) election.

 

 C: 
 2 

 

 

Whenever any shares of Restricted Shares granted under the terms of this Agreement vest or upon the making of a Section 83(b) election (a “Taxable Event”), the Grantee must remit or, in appropriate cases, agree to remit when due, the minimum amount necessary for the Company to satisfy all of its federal, state and local withholding (including FICA) tax requirements relating to such Taxable Event. The Grantee may satisfy these minimum withholding tax obligations by any (or a combination) of the following means: (i) a cash payment; (ii) withholding from compensation otherwise payable to the Grantee; or (iii) to the extent permitted by the Committee, by authorizing the Company to withhold from the Shares that become unrestricted as a result of the vesting of Restricted Shares a number of shares having a Fair Market Value, as of the date the withholding tax obligation arises, less than or equal to the amount of the withholding obligation. The Company will not deliver to the Grantee certificates for any shares of Common Stock otherwise deliverable to the Grantee as a result of the vesting of Restricted Shares unless the Grantee remits (or in appropriate cases agrees to remit) all applicable withholding tax requirements relating to the Taxable Event.

 

Miscellaneous Provisions.

 

· Change and Modifications. This Agreement may not be orally changed, modified or terminated, nor shall any oral waiver of any of its terms be effective. This Agreement may be changed, modified or terminated only by an agreement in writing signed by the Company and the Grantee.

 

· Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware without regard to conflict of law principles.

 

· Notices. All notices, requests, consents and other communications shall be in writing and be deemed given when delivered personally, by email, telex or facsimile transmission or when received if mailed by first class registered or certified mail, postage prepaid. Notices to the Company or the Grantee shall be addressed as set forth underneath their signatures below, or to such other address or addresses as may have been furnished by such party in writing to the other.

 

· Counterparts. For the convenience of the parties and to facilitate execution, this Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which shall constitute one and the same document.

 

 C: 
 3 

 

 

The foregoing Agreement is hereby accepted and the terms and conditions thereof hereby agreed to by the undersigned as of the date first above written.

 

    MYND ANALYTICS, INC.
       
  By:  
    Name:  
    Title:  

 

The undersigned hereby acknowledges receiving and reviewing a copy of the Plan, including, without limitation, Article 9 thereof, and understands that the Restricted Shares granted hereby are subject to the terms of the Plan and of this Agreement. This Agreement is hereby accepted, and the terms and conditions thereof and of the Plan hereby agreed to, by the undersigned as of the date first above written.

 

  GRANTEE:
   
   

 

 C: 
 4 

 

 

STOCK POWER

 

FOR VALUE RECEIVED and pursuant to that certain Restricted Shares Agreement between MYnd Analytics, Inc. (the “Corporation”), and [         ] (the “Grantee”) dated as of [ ], and the MYnd Analytics, Inc. Amended and Restated 2012 Omnibus Incentive Compensation Plan (the “Plan”), the Grantee hereby sells, assigns and transfers to the Corporation, an aggregate _________ shares of Common Stock of the Corporation, standing in the Grantee’s name on the books of the Corporation and represented by stock certificate number(s) _____________________________________________ to which this instrument is attached, and hereby irrevocably constitutes and appoints _________________ ____________________________________ as his or her attorney in fact and agent to transfer such shares on the books of the Corporation, with full power of substitution in the premises.

 

Dated ____________, 20_

 

     
  Signature  
     
     
  Name  

 

(Instruction: Please do not fill in any blanks other than the signature line. The purpose of the assignment is to enable the Corporation to exercise certain rights set forth in the Restricted Shares Agreement and the Plan without requiring additional signatures on the part of the Grantee.)

  

 C: 
 5 

 


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/31/22  Emmaus Life Sciences, Inc.        10-K       12/31/21   98:18M                                    ActiveDisclosure/FA
 8/10/21  Emmaus Life Sciences, Inc.        10-K/A     12/31/20   92:18M                                    ActiveDisclosure/FA
 5/04/21  Emmaus Life Sciences, Inc.        10-K       12/31/20   97:18M                                    ActiveDisclosure/FA
 1/25/21  Emmaus Life Sciences, Inc.        10-K       12/31/19  121:29M                                    ActiveDisclosure/FA
Top
Filing Submission 0001615774-16-009049   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., Apr. 24, 11:59:12.1pm ET